1. Ambrus, J. L., Ambrus, C. M., Gastpar, H., Huberman, E., Montagna, R., Biddle, W., Leong, S., and Horoszewicz, J., 1982, Antimetastatic and antitumor effect of platelet aggregation inhibitors. Interaction of Platelets and Tumor Cells, edited by G. A. Jamieson (New York: Liss), pp. 97?111.
2. Brown, D. L., 1976, Platelets in immunological reactions. Platelets in Biology and Pathology. Research Monographs in Cell and Tissue Physiology, edited by J. L. Gordon (Amsterdam: North-Holland), pp. 313?330.
3. Cucuaianu, M. P., Nishizawa, E. E., and Mustard, J. F., 1971, Effect of pyrimidopyrimidine compounds on platelet function. Journal of Laboratory and Clinical Medicine, 77, 958?974.
4. Donati, M. B., Rotillio, D., Delaini, F., Giavazzi, R., Mantovani, A., and Poggi, A., 1982, Animal models for the study of platelet-tumor cell interactions. Interaction of Platelets and Tumor Cells, edited by G. A. Jamieson (New York: Liss), pp. 159?176.
5. D'Souza, D., Daly, L., and Thornes, R. D., 1978, Levamisole, B.C.G. and warfarin as adjuvants to chemotherapy for increased survival in advanced breast cancer. Irish Journal of Medicine, 71, 605?608.